Hbm Pharmaceuticals Lahore

In: Business and Management

Submitted By saad42
Words 6121
Pages 25
Human Resource Management


Final Project
HR Manuel-HBM Pharmaceuticals Lahore






Submitted To:
Mr. Haroon Shabbir




Submitted By:

Muhammad Kashif 063832-045






Submission Date:
25-8-07










University of management and technology








table of Contents:



1. Company overview 5


2. Job Analysis: 7


2.1. Job Description of SPO: 7


2.2. Proposed Job Description of SPO: 8


2.3. Job Description of Store keeper: 9


2.4. Job Description of Accountants Manager: 10


2.5. Proposed Job Description of Accounts Manager: 11


2.6. Job Description of Director Sales & Finance: 12


2.7. Job Description of CEO 13


3. Recruitment and Selection Policy: 16


3.1 Recruiting phase: 16


3.1.1. Employee referrals/recommendations: 16


3.1.2. External searches: 16


3.2. Selection phase: 17


3.2.1. Initial screening: 17


3.2.2. Completed application: 17


3.2.3. Employment test: 18


3.2.4. Comprehensive interview: 18


3.2.5. Unconditional Job offers: 18


4. Socialization and Orientation Plan: 18


4.1. Socialization Process: 19


4.2. New-employee Orientation Process: 19


4.2.1. The CEO’s Role in Orientation: 19


4.2.2 HRM’s Role in Orientation: 20


5. Training and Development Plan: 20


5.1. Employee Training: 20


5.1.1. New employees: 20


5.1.2. Existing employees: 20


5.2. Determining training needs: 21


5.2.1. SPO: 21


5.2.2. Office staff: 21


5.2.3. RSM/ZSM: 21


5.2.4. The CEO and Director Sales: 22


5.3. Training Methods: 22


5.3.1. SPO: 22


5.3.2. RSM/ZSM: 22


5.4. Employee Development: 22


5.4.1. Employee Development Methods: 23


5.4.2. Developing Office Staff: 23


5.4.3. Developing SPO to Senior SPO: 23


5.4.4. Developing Senior SPO to RSM: 23


5.4.5.…...

Similar Documents

Merck Pharmaceutical

... president releases annual speech during shareholders meeting “The world is changing, and so is Merck. That makes it all the more important to have a reliable value compass to guide entrepreneurial actions. The financial and economic crisis has shown the negative consequences of not having such a compass – both for society and for companies themselves. We at Merck are taking a different path. Our values are courage, achievement, responsibility, respect, integrity and transparency. They determine our actions each and every day. Financial solidity and running our businesses judiciously are principles that enabled us to cope well with the crisis. Our actions are, of course, aimed at business success. At the same time, however, we respect and serve the interests of employees, customers and suppliers, investors and society. Only healthy companies that operate sustainably can contribute to a functioning society as employers, tax payers and corporate citizens. During the crisis, we deliberately renewed our commitment to the United Nations Global Compact. We did so because social and environmental responsibility is not a luxury to us that we only uphold during boom years, but rather are an integral part of our corporate culture. The examples described in this report provide evidence of this. We also take on responsibility for and with our pharmaceutical, chemical and life science products. Whether through innovative pharmaceuticals to treat disease, specialty chemicals to...

Words: 3445 - Pages: 14

Pharmaceutical

...The pharmaceutical industry has had to adjust their marketing strategy due to the 1984 Food and Drug Administration (FDA) legislation regarding drug patent protection. Traditional market strategy has also been affected by the changing face of the consumer. Drug companies have begun advertising to consumers. In the past, marketing strategy centered on marketing to doctors. The doctors were provided samples which they made available to patients. The nonmarket environment has affected the efficiency of the pharmaceutical industry. Consumers are more knowledgeable and they have more access to means of communication than they have in the past. Pharmaceutical companies are marketing their products to a consumer group that is more aware of ailments and the benefits of pharmaceutical treatment. Pharmaceutical industries traditional marketing plan includes providing samples of medicines to doctors. The industry also provides auxiliary office items (such as pen and personalized stationary) to medical professionals. The successful national and international sale of these samples funds the development of new pharmaceutical products. It is a cycle that must be completed due to the nature of selling doctor prescribed pharmaceutical products. Because of stringent oversight of the Food and Drug Administration, the pharmaceutical industry spends millions of dollars on research. Tang (2013) notes, on average developing a new drug has become increasingly expensive, time consuming and risky...

Words: 391 - Pages: 2

Pharmaceutical Companies, Intellectual Property

... and also an increase in the price of the drug. With the price increase the people in Africa will not be purchasing. By increasing the import cost and prices of drugs this then decrease the demand. By increasing tariff’s this denies millions of sick people access to what they need. 4. In June 2002, the WTO extended the transition period during which least-developed countries (LDCs) had to provide patent protection for pharmaceuticals. In your opinion, was this an appropriate change in policy or a dangerous precedent? What could be some of the negative ramifications of this resolution? What about the effects for other industries? -I agree that it is an appropriate change in policy. People tend to get greedy when large amounts of profit come flowing in blinding them of people’s real needs for help. The benefit of protecting the pharmaceutical patents is that it helps the poor get drugs at a lower cost actually giving them a chance, everyone deserves a chance. We are economically the most advanced compared to any other country we should want to help those who don’t have the means to help themselves. As many could potentially benefit from this policy it does have its problems. This policy would bring along some negative impact. For example, Pharmaceutical companies could face long term threats along with other risks. 5. Given the initiatives announced by global development and aid organizations and among pharmaceutical companies themselves, was it necessary to relax...

Words: 935 - Pages: 4

Pharmaceutical Supply Chain

...INTRODUCTION: GX International, Inc. has survived the fierce and cut-throat competition in the pharmaceutical industry for more than 20 years, it has withstood the test of time by embodying the vision of its founder which is to provide an option for Filipinos to have quality medicine at an affordable price. The supply chain department (known as the production department of GXI) has played an integral role in achieving the goal of continuously providing the lowest cost and sufficient supply of quality medicines through the years of GX’s existence. Through the constant effort of the supply chain officer to reduce the costs of materials, GX was able to maintain the selling price of its products for 12 years, until a significant change in the members of the top management and their ideals took over. The supply chain department and the company itself is at the verge of being out-dated by other companies through technological advancements, and its failure to adhere and adopt to the global standards and methods of supply chain management is placing the fate of the company in a very alarming situation. PROJECT NAME: The Implementation and Practice of Global Supply Chain Standards and Methodologies for a Filipino Pharmaceutical Company. DESCRIPTION OF THE PROJECT: The lack of knowledge on the global standards and methodologies in supply chain management, procrastination, and the lack of interest of the management to develop and adopt a more suitable and stable supply chain...

Words: 1453 - Pages: 6

Korea Pharmaceutical Directory

... Representative Fax No. sales@biosewoom.com 82-2-498-1189 1997 Total Sales (‘06) 5 Million $ Total The Number of Employees 20 (06‘) Contact Person Contact E-mail The Number of Researcher 6 (‘06) Contact Phone Contact Fax Jin you, Kim charmjy@biosewoom.co m 82-2-498-2340 82-2-498-1189 Introduction of Company Biosewoom is a manufacturer of advanced diagnostic reagents. 4. BORYUNG PHARM Company Representative Representative BORYUNG PHARM Kwang-Jin, Kim +82-2-708-8000 E-mail Representative Fax No. Phone No. Homepage Address Research Institute Address Year of Establishment The Number of Employees (07‘) Contact Person Contact E-mail http://www.boryung.co.kr Boryung Bldg 66-21 Wonnam-dong Jongro-gu Seoul, Rep of KOREA 112-3 Shingil-dong Danwon-gu Ansan-si Gyeonggi-do, Rep of KOREA 1963 Total 818 Hye-Kyung, Park turtle1981@boryung.co.kr Sales (‘07) The Number of Researchers (‘07) Contact Phone Contact Fax 200.0 Million$ Total 72 +82-2-708-8082 +82-2-708-8439 Introduction of Company Boryung, since its establishment in 1963, has been practicing the company mission of ‘Render a great contribution to human health’ and ‘Coexistence and coprosperity on the basis of humanism’ with the utmost effort. Boryung’s perseverance for over half a century includes researches, production of high-quality pharmaceuticals to precise shipping, all intended to liberate the nation from sickness. As a result, our products such as Gelfos M, Yongkaksan, and......

Words: 30709 - Pages: 123

Reliable Pharmaceutical Service

...Scope of the project: The scope of the project is to develop a web based application for Reliable Pharmaceutical Service to ease the existing system for its employees. The new web based application should be user friendly and should be hosted at the headquarters of Reliable Pharmaceutical Service. The existing data Reliable Pharmaceutical Service should be moved into the new web based application. Before the start of the development activities of the web based application, the activities like effort estimation, risk identification, budget allocation, resource identification etc should be completed to ensure hassle free development of the project. The effort estimation should be done very precisely to ensure the timely completion of the project. The testing of the web based application plays an important role in the successful project delivery therefore the software should be extensively tested so avoid any hiccups in the future. There will be several defects that may be identified during the testing phase. The resolution of all such defects is also in the scope of this project. The existing losses of Reliable Pharmaceutical Service are due to the complex system on which the whole company relies upon. The new web based application should work in such a way that Reliable Pharmaceutical Service should start making profits once again. The web based application so developed should be such that the widespread network of Reliable Pharmaceutical Service should be precisely...

Words: 260 - Pages: 2

Pharmaceutical Apprenticeship

... What is a Pharmaceutical Apprenticeship? Pharmaceutical Apprenticeships help Pharmaceutical Apprentices receive training to work towards nationally recognised qualifications for Dispensing Assistants and Pharmacy Technicians. Level 2 Intermediate Apprenticeship for Dispensing Assistants On successful completion of this course you will gain the following qualifications: • • • • Level 2 Certificate in Pharmaceutical Science (QCF) Level 2 NVQ Certificate in Pharmacy Service Skills (QCF) Level 1 Functional Skills: Maths Level 1 Functional Skills: English Course Structure Pharmaceutical Science (QCF) There are 6 units to complete for this course: • • • • • • Communicating with Pharmacy Clients Law, Regulations, Legislation & Health & Safety in Pharmacy Working in the Pharmacy Team & Industry Receiving, Storing & Maintaining Stock Processing Prescriptions Safe Assembly Prescriptions Pharmacy Service Skills (QCF) There are seven units to complete for this course: • • • • Ensure Your Own Actions Reduces Risks to Health & Safety. Meeting Client’s Needs, Receiving & Assembling Prescribed Items. How to Order & Receive Pharmaceutical Stock Team-work in Pharmacies Functional Maths & English Level 1 These skills tests will be taken alongside your Apprenticeship to make sure that you have a good understanding of Maths and English which is essential to future job success. For more information contact Pathway Group on 0800 955 0870 or 0121 707 0550 or...

Words: 570 - Pages: 3

Pharmaceutical

... lack of new consumer products threatened the strength of the company, in turn encouraging the merger with their competitor Sharp and Dohme, Inc. In 1965, control of the company shifted for the first time to a non-Merck family member when Henry Gadsen became CEO. Under Gadsen, many smaller pharmaceutical companies were brought into the Merck family, including Calgon, Kelco, and Aircoil. By the 1980s, Merck was the largest producer of drugs for the major markets of the United States, Europe, and Japan. Merck Today: Today Merck employs over 55,000 and produces some of the most well-known pharmaceutical products on the market, including Singulair and Gardasil. The company's interests range from pharmaceuticals, vaccines and veterinary health to consumer education. Merck reported 2008 earnings as almost $24 billion, with the predominant profits made in the United States. References * Marshall, J., & Olphert, A. (2008, December). Understanding the effects on staff and patients in the NHS: A case study of local Primary Care Trust Mergers. Management Services, 52(4), 20-24, 26-28; * Weiner, S., & Hill, R. (2008). SEVEN STEPS TO MERGER EXCELLENCE. Ivey Business Journal Online, 72(5), 2-4. R; * Arnum, Patrica Van. (Aug. 2009). Big Pharma Tightens Its Belt in Global Manufacturing. Pharmaceutical Technology. 33(8). Page 34-37; * Fagerberg, Paula. (2002, October). Merck: with affinity groups and programs for innovative leadership, this pharmaceuticals......

Words: 4970 - Pages: 20

Pharmaceutical Industry

...Environment Environment movements are real threats for Pharmaceutical industry as these movements focus on green environments and reduce chemicals and carbon which comes from pharmaceutical industries. It is not being possible to ignore these issues as they are supposed to be practiced under United Nation charter for clean and better environment. For example Pfizer is a well reputed British Pharmaceutical company which has aims to save the environment as much as possible from chemicals, waste water which includes active pharmaceutical ingredients mixture of different compounds and carbon which comes from their pharmaceutical industries. Different strategies could be used to reduce carbon and chemical waste from drugs for human environment, like proper consumption ,good way of savages for hospitals waste water like advance waste water treatment technology, private house hold expire drugs, training and education of medical professionals to reduce over prescription, and public education and awareness. These strategies could be help full for save green house environment from drugs. In conclusion if we do focus on three principal strategies to reduce the input of chemicals compounds, carbon, and waste water in to the environment are substitution of complex chemical compounds, advance technical approach, and proper education and training of doctors, retailers and consumers. (Klaus Kümmerer, 2009) Social The social life, physical activities and level of health of a community...

Words: 1468 - Pages: 6

Bangladesh’s Growing Pharmaceutical Sector

...Bangladesh’s growing pharmaceutical sector The export value of pharmaceuticals is growing at a reasonable rate every year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007 and posted further gains last year. Export destinations are also increasing in number. Beginning in the 1950s, when a few multinationals and local entrepreneurs set up manufacturing facilities in the then East Pakistan, now over 200 companies produce now medicines in Bangladesh. The pharmaceutical industry in Bangladesh has otherwise the potential to grow and enjoy a number of competitive advantages. Quality assurance has put the industry on a solid base. Almost all companies follow the World Health Organisation (WHO) Good Manufacturing Practice (GMP) standards. Bangladesh’s strict quality compliance gives pharmaceuticals an advantage to compete with producers in India, China, Brazil and Turkey in the overseas export markets. The capability of the industry has helped it achieve excellence as per the general international standards. A good number of local pharmaceutical companies have won accreditation from the overseas regulatory authorities including some of those in the developed countries. Two such local companies have been accredited by EMEA (Austria) and the Therapeutic Goods Administration (TGA-Australia). The accreditation facilitates their entry into the lucrative market as reputed players. Bangladesh’s national drug policy requires strict standards compliance from the...

Words: 686 - Pages: 3

Pharmaceutical Sector in Bangladesh

...Pharmaceutical sector in Bangladesh In Bangladesh Pharmaceutical sector is one of the most developed hi tech sector which is contributing in the country’s economy. After the promulgation of Drug Control Ordinance – 1982, the development of this sector was accelerated. This sector is also providing 95% of the total medicine requirement of the local market. In 2000, there were 210 licensed allopathic drug-manufacturing units in the country, out of which only 173 were on active production; others were either closed down on their own or suspended by the licensing authority for drugs due to non compliance to GMP or drug laws. They manufactured about 5,600 brands of medicines in different dosage forms. There were, however, 1,495 wholesale drug license holders and about 37,700 retail drug license holders in Bangladesh. Anti-infective is the largest therapeutic class of locally produced medicinal products, distantly followed by antacids and anti-ulcerates. Top pharmaceutical company 1. Square Pharmaceuticals Ltd. 2. Incepta Pharmaceuticals Ltd. 3. Beximco Pharma ltd. 4. Bio-pharma Ltd. 5. Opsonin Pharma Ltd. 6. Eskayef 7. Renata Pharmaceuticals 8. Acme Pharmaceuticals 9. Aci Pharmaceuticals 10. Aristopharma 11. Drug International 12. Sanofi Aventis 13. Glaxosmithkline 14. Orion pharma bangladesh 15. Novo Nordisk 16. Healthcare Pharmacy 17. Ibn Sina 18. Sandoz 19. Popular Pharmaceutical Ltd. 20...

Words: 951 - Pages: 4

Pharmaceutical

...Instructor’s Manual CASE TEACHING NOTES The Global Pharmaceutical Industry Sarah Holland (Manchester Business School) and Bernardo Bátiz-Lazo (London South Bank University) 1. Introduction The case describes how the prescription pharmaceutical industry has changed since its modern beginnings in the early 1950s. The various forces affecting the competitive environment of the industry are discussed in terms of origins, immediate past and immediate future (2004 onwards). As a result, the note provides insights into the evolution of barriers to enter and exit the industry for prescription pharmaceuticals, while aiming to help students to recognise how to set boundaries for an industry. This is a detailed industry note on the “ethical” pharmaceutical industry which provides an opportunity to analyse key success factors of major players. The note centres on a descriptive overview of the predominant issues in the three major Triad market areas: the US, Europe and Japan (although major issues in emerging markets are also mentioned). The note covers the overall industry environment with in-depth discussion of the driving forces in the industry such as globalisation (in particular global regulatory issues, changing world demographics and worldwide pricing disparities); development of new technology; the importance of time to market; and amalgamations. The case also examines issues around corporate social responsibility. 2. Position of the Case The pharmaceutical...

Words: 8602 - Pages: 35

Pharmaceutical Industries

...INTERNSHIP REPORT ON TRAINING AND DEVELOPMENT PRACTICES OF INCEPTA PHARMACEUTICALS LTD. Submitted To: Mr. Shamim Ehsanul Haque Senior Lecturer BRAC Business School Submitted By: Nusrat Jahan Trisha ID – 09204115 BRAC Business School TABLE OF CONTENTS Title Page No Part- Ι Letter of Transmittals 5 Acknowledgement 6 Executive Summary 7 Part- ΙΙ Introductory Part 08-19 1.0 Introduction 09 1.1 Rationale of the Study 10 1.2 Objectives of the Study 11 2.0 Company overview 12-19 2.1 Profile of Incepta Pharmaceuticals Ltd. 12 2.2 History of IPL 12-13 2.3 Vision of IPL 13 2.4 Mission of IPL 13 2.5 Incepta Pharmaceuticals Ltd. at Glance 14 2.6 Divisions & Departments of IPL. 15 2.7 Organizational Hierarchy of IPL 16 2 2.8 Growth Rate of IPL 17 2.9 Products of IPL 18 2.10 CSR of IPL 19 ACTIVITIES UNDERTAKEN 20-37 3.1 Overview of HR practices in Incepta Pharmaceuticals Ltd. 21 3.1.1 Discussion about HRM 21 3.1.2 Functional area of HRM in Large Organization 21-22 3.1.3 Incepta Functional area of HRM 22-24 3.2 Overview of Training and Development Function of Incepta 25-44 3.2.1 Training Defined 25 3.2.2 Development 25 3.2.3 Importance of Training and Development 26 3.2.4 Review of Training function of Incepta 27 3.2.5 Types of training 28 3.2.6 Incepta Behaviors 29 3.2.7 Employee...

Words: 9658 - Pages: 39

Pharmaceutical Advertising

...Pharmaceutical Advertising Pharmaceutical advertising, which dates back to the 18th and 19th century, conveys a message to consumers in which medication can relieve just about any ailment. Today, these ads are everywhere. They exist on billboards, television, radio, the newspaper, magazines, and the Internet. Direct-to-consumer marketing (DTC) almost challenges the individual to question whether or not he or she has a medical issue. This is synonymous with selling an illness and not a remedy. Pharmaceutical advertising and marketing among health care providers remains questionable in terms of ethical practices. Pharmaceutical representatives promote their medications through a commonly known marketing strategy, which involves the use of gifts to entice or persuade the health care provider. These gifts involve pens, pads, lunch, dinner, and luxurious trips. Effective advertising and marketing should promote a product that gains the interest of an individual without question. Advertising, mainly in the form of pharmaceuticals should not be misleading and should not insinuate that common occurrences produce a medical problem. The History of DTC Marketing Originating in the 18th and 19th century, DTC marketing deluded consumers through misleading and falsified advertising. Moving on into the 20th century, “pharmaceutical ads accounted for nearly half of newspapers’ advertising revenue” (Huh, DeLorme, Reid, & Soontae, 2010, para. 3). The Pure Food and Drug Act became a law...

Words: 927 - Pages: 4

Veterinary Pharmaceutical Compounding Overview

...Veterinary Pharmaceutical Compounding Overview Let’s start off with a little background information to set the stage. The pet industry has grown continuously since 1994 despite changes in the economy. Putting things in perspective, this industry is the second highest-growth industry after consumer electronics. In 2009, the value of the U.S. market for pet care was estimated at $46 billion. This is expected to increase to $56.5 billion by the end of 2014, for a compound annual growth rate (CAGR) of 4.2%. See the table below for a breakdown of the segments, within the pet care market, which would be of interest to a pharmacy setting. When looking at the table, notice the percent change in CAGR for the Other Pet Supplies. This change is phenomenal and mainly due to the increased usage of OTC medications. Human OTC medications that are approved for usage by companion animals are Imodium, Pepto-Bismol (use in dogs only), Benadryl, Aspirin (use in dogs only), Dramamine, Tagamet, Pecid-AC, Zantac, Hydrocortisone, Gas-X, Glucosamine, antibiotic ointments, antibacterial soap, hydrogen peroxide, and saline nasal sprays. Veterinary OTC medications include the best-selling and most popular flea and tick preparations (Frontline, Advantage, Bio Spot) and pet health supplements. Under the segment of Veterinary Care is where compounding can be found. In 2010, veterinary compounded product sales reached $300 million. Demographics of pet owners According to the 2011-2012...

Words: 768 - Pages: 4